Peptide Skincare & BeautySkin science and ingredient guides

Skin science article

GHK-Cu Dosage Chart: 50 mg Vial Protocol

GHK-Cu (50 mg Vial) Dosage Protocol GHK-Cu Dosage Chart This GHK-Cu dosage chart explains a 50 mg vial prepared to a final volume of 3.0 mL for a concentration of 16.67 mg/mL. The GHK-Cu dosage protocol examples below cover 1.0 mg, 1.5 mg, and 2.0 mg amounts,

GHK-Cu (50 mg Vial) Dosage Protocol

GHK-Cu Dosage Chart

This GHK-Cu dosage chart explains a 50 mg vial prepared to a final volume of 3.0 mL for a concentration of 16.67 mg/mL. The GHK-Cu dosage protocol examples below cover 1.0 mg, 1.5 mg, and 2.0 mg amounts, with matching U-100 syringe units, reconstitution steps, supplies, and research context.

Reconstitute: Prepare the 50 mg vial to a final volume of 3.0 mL for a concentration of 16.67 mg/mL.

Research protocol range: The tables below cover 1.0 mg, 1.5 mg, and 2.0 mg using the standard and alternative research-use schedules.

Easy measuring: At 16.67 mg/mL, 1 U-100 unit = 0.01 mL = approximately 166.7 mcg.

Quick conversions: 1.0 mg = 6 units, 1.5 mg = 9 units, and 2.0 mg = 12 units.

GHK-Cu, or glycyl-L-histidyl-L-lysine copper complex, is a naturally occurring copper peptide studied for collagen-related pathways, tissue remodeling, antioxidant defense, and skin repair[7][8]. This educational GHK-Cu dosage protocol presents the same research-use schedule for the 50 mg vial, with calculations adjusted for its concentration.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read GHK-Cu Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Standard / Conservative Approach (3 mL = 16.67 mg/mL; 5 days/week)

Weeks 1-4

1.0 mg (1000 mcg)

6 units (0.06 mL)

Weeks 5-8

1.5 mg (1500 mcg)

9 units (0.09 mL)

Weeks 9-12+

2.0 mg (2000 mcg)

12 units (0.12 mL)

Frequency: Once daily, 5 days per week, progressing from 1.0 mg to 1.5 mg and then 2.0 mg as shown above. At 16.67 mg/mL, those doses equal 6, 9, and 12 U-100 units[18]. Use a U-100 syringe with markings that clearly display every value in the table.

Reconstitution Steps

Draw 3.0 mL of the protocol-specified sterile diluent with a sterile syringe.

Add it slowly down the vial wall to reduce foaming.

Gently swirl or roll until dissolved. Do not shake.

Label the vial with the 16.67 mg/mL concentration, preparation date, and storage instructions.

Alternative Protocol (3 mL = 16.67 mg/mL; 3 times weekly)

Weeks 1-12+

Frequency: 2.0 mg three times per week, such as Monday, Wednesday, and Friday. At 16.67 mg/mL, each injection equals 12 U-100 units (0.12 mL), for approximately 6 mg per week[18].

Supplies Needed

Plan based on an 8-16 week protocol. Calculations are shown for both the 5 days/week and 3 times/week schedules.

Peptide Vials (GHK-Cu, 50 mg each):

5 days/week (1.0-2.0 mg/day):

8 weeks (~50 mg total): 1 vial

12 weeks (~90 mg total): 2 vials

16 weeks (~130 mg total): 3 vials

3 times/week (2 mg each):

8 weeks (~48 mg total): 1 vial

12 weeks (~72 mg total): 2 vials

16 weeks (~96 mg total): 2 vials

Insulin Syringes (U-100, 29-31 gauge):

5 days/week:

Per week: 5 syringes

8 weeks: 40 syringes

12 weeks: 60 syringes

16 weeks: 80 syringes

3 times/week:

Per week: 3 syringes

8 weeks: 24 syringes

12 weeks: 36 syringes

16 weeks: 48 syringes

Sterile or Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for the displayed calculation.

1 vial: 3 mL

2 vials: 6 mL

3 vials: 9 mL

Alcohol Swabs: Two administration swabs per injection: one for the vial stopper and one for the injection site.

Per week: 10 swabs

8 weeks: 80 swabs or 1 x 100-count box

12 weeks: 120 swabs or 2 x 100-count boxes

16 weeks: 160 swabs or 2 x 100-count boxes

Per week: 6 swabs

8 weeks: 48 swabs or 1 x 100-count box

12 weeks: 72 swabs or 1 x 100-count box

16 weeks: 96 swabs or 1 x 100-count box

The reference edit

Ingredients, questions
& further reading.

Connected source records selected through this article’s public topic index.

01

Formula cabinet

Ingredients & structured notes

Ingredient index

Can GHK-Cu be used with other active ingredients like Vitamin C or Retinol?

  1. 01Yes, GHK-Cu is generally compatible with many other active ingredients. However, we advise applying GHK-Cu first, allowing it to absorb, before applying stronger actives like high-concentration Vitamin C or Retinol. This approach helps minimize pote…
Source · realpeptides.co
02

Product index

Related product references

Product

Lovely Southern GHK-Cu Repair Serum

Lovely Southern GHK-Cu Repair Serum Ingredients in Lovely Southern GHK-Cu Repair Serum explained: benefits, concerns, and detailed analysis of 9 ingredients including Water, Sodium Hyaluron…

Source: skinsort.comView reference →
03

Comparison edit

Read side by side

Topical vs Injectable GHK-Cu: Which Is Better?

Both delivery methods work. The right choice depends on your goal. Bioavailability Lower (dermis penetration proven, limited depth) Higher (10 to 20x tissue concentration) Best for Facial s…

GHK-Cu Cosmetic Formulation Comparison

When evaluating the best GHK-Cu Cosmetic for skin care, understanding the nuances of different formulations is crucial. This table outlines key factors we consider at Real Peptides to help …

04

Ask the journal

Related questions

01What If You're Using a Topical GHK-Cu Product That Feels Ineffective?

Verify the formulation contains a penetration-enhancing vehicle. GHK-Cu's molecular weight allows passive diffusion through skin, but only if solubilized in a lipophilic base or encapsulated in liposomes. Aqueous creams or serums without these features show Franz cell permeation rates below 5% of the applied dose. Research from the International Journal of Cosmetic Science demonstrates that propylene glycol at 10–20% w/w increases GHK-Cu dermal delivery 4-fold compared to water-based vehicles, and liposomal formulations achieve even greater penetration by bypassing the stratum corneum entirely through vesicle fusion with skin lipids.

Source · realpeptides.co
02What If I Combine GHK-Cu With Retinoids or Vitamin C?

Avoid applying GHK-Cu and L-ascorbic acid (vitamin C) in the same routine. Ascorbic acid's low pH (2.5–3.5) disrupts copper coordination and reduces GHK-Cu bioavailability by approximately 60%. Use vitamin C in morning application and GHK-Cu at night, or separate applications by at least 8 hours. Retinoids (tretinoin, adapalene) can be combined with GHK-Cu. In fact, a 2019 study published in the Journal of Cosmetic Dermatology found that GHK-Cu applied 30 minutes after tretinoin reduced retinoid-induced irritation by 40% while maintaining the collagen-stimulating effects of both compounds. The mechanism: GHK-Cu's anti-inflammatory effects (mediated by reduced IL-6 and TNF-α secretion) counteract the transient inflammation tretinoin causes during the retinization period. Apply tretinoin first, wait 20–30 minutes for penetration, then apply GHK-Cu as a second layer.

Source · realpeptides.co
03What If My GHK-Cu Serum Turns Blue-Green?

Discard it immediately. Color change indicates copper oxidation and peptide degradation. Copper peptides are chemically unstable in aqueous solution. Oxidized copper forms Cu²⁺ complexes that generate reactive oxygen species, which degrade the GHK backbone and denature the peptide structure. Studies show that oxidized GHK-Cu loses 80% of its MMP-activating capacity within 48 hours of discoloration. Store all copper peptide products at 2–8°C and use within 60 days of opening.

Source · realpeptides.co
04What If I Only Use Topical GHK-Cu and Skip Injections?

Topical application at 2–3mg delivers 8–12% fibroblast bioavailability due to epidermal barrier thickness in 30s skin. That's sufficient for localized photoaging prevention (crow's feet, forehead lines) but inadequate for generalized collagen maintenance. If systemic signaling is your goal, subcutaneous administration is the more reliable route. Reserve topical for targeted areas. Not full-face protocols.

Source · realpeptides.co
05What If I'm Using GHK-Cu in a Multi-Peptide Stack?

Calculate each peptide's concentration independently and use separate syringes for each draw. Mixing reconstituted peptides in the same syringe barrel before injection. A shortcut some researchers attempt to reduce injection count. Risks peptide-peptide interactions that alter bioavailability or cause precipitation. GHK-Cu's copper ion can chelate with other peptides containing histidine or cysteine residues, forming inactive complexes. Draw and inject each peptide separately, even if they're administered at the same anatomical site.

Source · realpeptides.co
05

Source shelf

Research & excerpts

Research note

Cognitive Function and Synaptic Plasticity Research

Beyond neuroprotection, GHK-Cu’s BDNF modulation has implications for synaptic plasticity research — the cellular basis of learning and memory consolidation. BDNF is required for long-term potentiation (LTP) at hippocampal synapses, and reduced BDNF signalling impairs LTP induction and memory consolidation. Research examining GHK-Cu’s effects on hippocampal BDNF expression and LTP induction protocols would clarify whether GHK-Cu’s BDNF-upregulating effects translate to measurable improvements in synaptic plasticity endpoints. Ageing is associated with progressive hippocampal BDNF decline and corresponding deficits in LTP and spatial memory in rodent models. Research in aged animals using GHK-Cu has an established biological rationale for examining BDNF restoration and cognitive outcomes — analogous to the dermatological research that validated GHK-Cu’s capacity to restore youthful gene expression patterns in aged skin fibroblasts.

Source · peptideslabuk.com

Research note

Clinical Trial Data on Hair Density and Thickness Outcomes

The most rigorous GHK-Cu studied androgenetic alopecia research comes from a 2018 randomised controlled trial comparing topical GHK-Cu 2% solution versus minoxidil 5% over 12 weeks in 60 male patients with Norwood Stage II–IV androgenetic alopecia. Results: GHK-Cu group showed mean hair density increase of 28 hairs per cm² versus 19 hairs per cm² in the minoxidil group (p<0.05). Hair shaft diameter increased by 12% in the GHK-Cu cohort versus 6% in minoxidil. Notably, side effects were reported in 4% of GHK-Cu users (mild scalp irritation) versus 18% in minoxidil users (scalp dryness, contact dermatitis). The trial used phototrichogram analysis. A gold-standard measurement where scalp regions are shaved, photographed at baseline and endpoint, and hair counts digitally quantified under magnification. A separate 2020 study from researchers at the University of Naples examined GHK-Cu combined with caffeine and biotin in a triple-action topical formulation. That study enrolled 45 women with female pattern hair loss (Ludwig Stage I–II). After 20 weeks of twice-daily application, mean hair density increased 23% and patients reported subjective improvements in hair thickness and manageability. The formulation used 1.5mM GHK-Cu, 0.2% caffeine, and 0.1% biotin in a liposomal delivery base. What's significant: the liposomal encapsulation increased peptide penetration efficiency by approximately 40% compared to aqueous solutions based on dermal biopsy sampling at week 10. Liposomal GHK-Cu accumulated in the follicular infundibulum and dermal papilla region. Exactly where androgenetic alopecia pathology originates.

Source · realpeptides.co